Loading clinical trials...
Loading clinical trials...
Although impressive progress has been made with this new therapeutic strategy, only a proportion of patients achieve a complete and sustained response. Studies have already identified predictive facto...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Strasbourg, France
NCT05079113 · Stage III Melanoma, Stage IV Cutaneous Melanoma
NCT00019890 · Stage IV Melanoma, Stage III Melanoma, and more
NCT00945269 · Recurrent Melanoma, Stage III Melanoma, and more
NCT02794636 · Stage III Melanoma
NCT00349206 · Melanoma, Recurrent Melanoma, and more
Service de dermatologie - Réanimation - CHU de Strasbourg - France
Strasbourg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions